| 9.87 Delayed Data As of Jul 22 |  +0.01 / +0.10%Today’s Change | 8.63 Today|||52-Week Range 15.91 | -4.17% Year-to-Date |
| Prothena Announces Appointment of Paula K. Cobb to its Board of Directors Jul 01 / GlobeNewswirePNW - Paid Partner Content |
| Previous close | 9.86 |
| Today’s open | 9.89 |
| Day’s range | 9.77 - 10.02 |
| Volume | 94,252 |
| Average volume (3 months) | 273,695 |
| Market cap | $393.1M |
| Earnings growth (last year) | +3.33% |
| Earnings growth (this year) | +42.79% |
| Earnings growth (next 5 years) | -6.99% |
| Revenue growth (last year) | -96.53% |
| P/E ratio | NM |
| Price/Sales | 426.66 |
| Price/Book | 1.22 |
| Today’s change | Today’s % change | |
|---|---|---|
| PRVLPrevail Therapeutics... | +0.56 | +4.81% |
| SRRKScholar Rock Holding... | -0.42 | -3.19% |
| MITOStealth BioTherapeut... | +0.17 | +1.50% |
| REPLReplimune Group Inc | +0.23 | +1.90% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | -$0.56 |
| Annual revenue (last year) | $955.0K |
| Annual profit (last year) | -$155.6M |
| Net profit margin | -16,297.91% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Gene G. Kinney |
Chief Operating & Financial Officer Tran B. Nguyen |
Corporate headquarters Dun Laoghaire, Dublin |
